文献速递耳科与耳神经头颈外科

前庭神经鞘瘤临床分期预测术后严重并发症

Clinical Staging to Estimate the Probability of Severe Postoperative Complications in Patients With Vestibular Schwannoma.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2021-01-01

本研究基于1998至2020年单中心185例手术治疗的散发性前庭神经鞘瘤患者,采用Clavien-Dindo分级评估术后30天内严重并发症。结果显示40例(22%)发生严重并发症,结合症状与肿瘤大小的4期临床严重度分期系统区分严重并发症的C指数为0.754(95%CI 0.67-0.84),优于仅用肿瘤大小的模型(C指数0.706,95%CI 0.62-0.79)。

要点

  • 22%患者术后30天内发生严重并发症(Clavien-Dindo≥3级)。
  • 大型肿瘤(最大径>2.5 cm)、前庭症状及近期听力下降与严重并发症相关。
  • 4期临床严重度分期系统区分严重并发症能力优于单纯肿瘤大小模型。

核心结论

  • 前庭神经鞘瘤患者初诊时的症状联合肿瘤大小可预测术后严重并发症。
  • 纳入初诊症状的新临床严重度分期系统有助于识别高危患者。

研究设计与样本

  • 纳入185例在华盛顿大学接受手术治疗的散发性前庭神经鞘瘤患者。

主要发现

  • 185例中40例(22%)发生严重术后并发症(Clavien-Dindo≥3级)。
  • 40例严重并发症患者中20例(50%)为女性,平均(SD)年龄46(13)岁。
  • 严重并发症患者更常见大型肿瘤(最大径>2.5 cm)、前庭症状及近期听力下降。

关键数值与推荐

  • 采用联合合并法构建4期临床严重度分期系统,纳入初诊症状与肿瘤大小。
  • 临床严重度分期系统区分严重并发症的C指数为0.754(95%CI 0.67-0.84)。
  • 仅肿瘤大小模型的C指数为0.706(95%CI 0.62-0.79)。

临床怎么用

  • 临床可利用初诊症状与肿瘤大小对前庭神经鞘瘤患者进行严重并发症风险分层。

局限性

  • 回顾性单中心研究,样本量185例,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Vestibular schwannomas have long been treated as a homogeneous entity. Clinical symptoms at presentation may help elucidate the underlaying pathophysiologic characteristics of tumor subtypes. Describing the heterogeneity of these benign tumors may assist in predicting clinical outcomes associated with their treatment. OBJECTIVE: To create a tumor staging system that incorporates symptoms at presentation and tumor size to predict severe surgical complications. DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohort of patients at a single-center tertiary referral center from January 1, 1998, to October 13, 2020, was studied. Patients diagnosed with sporadic vestibular schwannoma surgically treated at Washington University in St Louis, Missouri, were included. MAIN OUTCOMES AND MEASURES: Severe surgical complications within 30 days of surgery as determined by the Clavien-Dindo classification system. Patients experiencing a complication of grade 3 or above were determined to have a severe complication. RESULTS: Of 185 patients evaluated, 40 (22%) had severe postoperative complications. Twenty of the 40 patients (50%) were women; mean (SD) age was 46 (13) years. Patients with severe complications were more likely to have large tumors (>2.5 cm in largest diameter), vestibular symptoms, and recent hearing loss at presentation. Using conjunctive consolidation, a 4-stage clinical severity staging system that incorporates clinical symptoms and tumor size at presentation was created to predict severe complications. The clinical severity staging system demonstrated an improvement in the ability to discriminate severe complications (C index, 0.754; 95% CI, 0.67-0.84) from a model of tumor size alone (C index, 0.706; 95% CI 0.62-0.79). CONCLUSIONS AND RELEVANCE: This cohort study found that, among patients with vestibular schwannoma, symptoms present at initial evaluation, in addition to tumor size, served as predictors of severe postoperative complications. A new clinical severity staging system incorporating symptoms at presentation can be helpful for clinicians to identify patients at high risk for severe postoperative complications.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Smith HJ, Durakovic N, Patel B, et al. Clinical Staging to Estimate the Probability of Severe Postoperative Complications in Patients With Vestibular Schwannoma. JAMA Otolaryngol Head Neck Surg. 2021. PMID: 34617972. doi:10.1001/jamaoto.2021.2626

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。